Trimetoprime Bağlı Gelişen Tip IV Renal Tübüler Asidoz
Öz
Anahtar Kelimeler
References
- Thomas CF, Limper AH. Pneumocystis pneumonia. N Engl J Med 2004;350:2487-98
- William AP. Sulfonamides, Trimethoprim-sulfamethoxazole, quınolones. Brunton LL, Lazo ZS, Parker KL. Goodman & Gilman’s the pharmacologıcal basis of therapeutics. The McGraw- Hill Companies. 11th ed. 2006; 458-63.
- Lin SH, Kuo AA, Yu FC, Lin YF. Reversible voltage- depent distal renal tubular acidosis in a patient receiving standart doses of trimethoprim- sulphamethoxazole. Nephrol Dial Transplant. 1997;12:1031-3.
- Murphy JL, Griswold WR, Reznik VM, Mendoza SA. Trimethoprim / sulphamethoxazole- induced renal tubuler acidosis.Child Nephrol Urol.1990;10:49-50.
- Domingo P, Ferrer S, Cruz J, Morla R, Ris J. Trimethoprim- sulphamethoxazole-induced renal tubuler acidosis in a patients with AIDS. Clin Infect Dis. 1995;20:1435-7.
- Sheehan MT, Wen SF. Hyperkalemic renal tubuler acidosis induced by trimethoprim/sulphamethoxazole in an AIDS patient. Clin Nephrol.1998;50:188-93.
- Margassery S, Bastani B. Life threatening hyperkalemia and acidosis secondary to trimethoprim- sulphamethoxazole treatment.J Nephrol. 2001;14:410-4.
- Singer GG, Brenner BM. Fluid and electrolyte disturbances. Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, et al. Harrison’s Principles of Internal Medicine.The McGraw- Hill Companies.17th ed.2008;283-5.
Details
Primary Language
Turkish
Subjects
-
Journal Section
-
Authors
İrfan Yavaşoğlu
Gökhan Sargın
Gürhan Kadıköylü
Ali Zahit Bolaman
Publication Date
September 1, 2011
Submission Date
-
Acceptance Date
-
Published in Issue
Year 2011 Number: 3